SECTOR / PHARMA

Find the launch story that grows peak share.

For launch strategy and commercial teams: test positioning, access, and support decisions before the budget locks. Subconscious turns one plausible launch story into thousands of measured experiments on simulated prescribers, payers, and patients.

2 in 3

New drugs often miss prelaunch expectations. The molecule is only part of the bet. The money is in knowing which story, access path, and support model changes behavior.

Source: McKinsey, The secret of successful drug launches

THE TIMING SHIFT

Today
  1. Evidence
  2. Positioning
  3. Access
  4. Readiness
  5. Launch
Subconscious
  1. Evidence
  2. Positioning
  3. Access
  4. Readiness
  5. Launch
Current launch research arrives after the story is already heavy. Subconscious tests the story while it can still change.

CAUSAL OPERATING LOOP

KPI shift

More launch upside, before the plan hardens.

Peak share

The launch story hardens before behavior is tested.

Positioning, access, and support ranked by causal lift.

Access risk

Payer friction shows up after field plans are locked.

Access tradeoffs are tested before the budget commits.

Review confidence

Claims are defended after the story is chosen.

Every recommendation carries cohort, interval, and trail.

Relative decision leverage. Every read ships with cohort, confidence interval, and experiment trail.
Pharma causal decision graphPrescriber and access context confound the relationship between launch decisions and prescribing, persistence, and peak share. Subconscious isolates the causal effect.Umarket contextunobserveddo(S)positioning / access / supportYRx / persistence / share
Grey arrows are the assumptions hiding in the launch plan. The red arrow is the causal effect of positioning, access, and support on prescribing, persistence, and peak share.

ONE CAUSAL ANSWER

Which story makes prescribers choose you when the market gets crowded?

Walk into launch readiness with the territories, access moves, and support offers ranked by expected lift. Strategy gets the causal answer, not another round of consensus.

PROOF

93%

validated against human outcomes

350+

replicated human studies

5 min

to run the next decision

SOC 2

enterprise-ready deployment